SCHEMBL6513255

SCHEMBL6513255

O=C(Nc1cc(Oc2ccc3c(ccn3C(=O)N3CCOCC3)c2)ccn1)Oc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.42
GCK P35557 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
KMT2A Q03164 4/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 2/20 0.38
MEN1 O00255 2/20 0.38
MET P08581 1/20 0.38
HTT P42858 2/20 0.37
KDM4E B2RXH2 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HPGDS O60760 1/20 0.36
ABL1 P00519 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KDR P35968 2/20 0.36
FGFR2 P21802 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038382 0.89 FGFR1 (0.44) FGFR1GCKMETHTTKDR
SCHEMBL6038474 0.87 HSD17B10 (0.40) HSD17B10PIK3CDPIK3CAPIK3CBKMT2A
SCHEMBL5115425 0.83 HSD17B10 (0.41) HSD17B10KMT2ANPC1RAB9APOLB
SCHEMBL5114627 0.83 FGFR1 (0.43) FGFR1GCKPIK3CDPIK3CAFGFR3
SCHEMBL5108431 0.82 FGFR1 (0.42) FGFR1METFGFR3
SCHEMBL5107824 0.82 GCK (0.53) FGFR1GCKFGFR3
SCHEMBL6038471 0.81 HSD17B10 (0.40) HSD17B10KMT2ANPC1RAB9APOLB
SCHEMBL5107702 0.81 GCK (0.42) FGFR1GCKABL1KDRFGFR3
SCHEMBL5102704 0.80 GCK (0.45) FGFR1GCKKDRFGFR3
SCHEMBL5104756 0.80 DYRK3 (0.43) FGFR1HSD17B10KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187236-A1 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187236-A1 Nitrogen-containing aromatic derivatives NR0B2, NR0B1, NR4A1 FGFR1 595/4885GCK 3607/4885HSD17B10 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.